CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.85+0.19 (+11.45%)
Close on Nov 17, 2026Market cap $32.54MP/E –Yield –
Cel Sci revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2014 it was $264.03K, up 65.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | $264.03K | +65.5% |
| FY2013 | Sep 30, 2013 | $159.58K | -37.3% |
| FY2012 | Sep 30, 2012 | $254.61K | -73.4% |
| FY2011 | Sep 30, 2011 | $956.15K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $17.39K | – |
See a number that looks wrong?